Vivos (RDGL) EBIT Margin (QoQ) (2011 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Vivos | - | - | -3,105.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.38 Mn |
| Sep 30, 2025 | -2.38 Mn |
| Jun 30, 2025 | -127,008.00 |
| Mar 31, 2025 | 1.00 Mn |
| Dec 31, 2024 | 361,365.00 |
| Sep 30, 2024 | -1.30 Mn |
| Jun 30, 2024 | 895,613.00 |
| Sep 30, 2023 | 424,444.00 |
| Jun 30, 2023 | -992,914.00 |
| Mar 31, 2023 | 671,924.00 |
| Dec 31, 2022 | -659,533.00 |
| Sep 30, 2022 | 323,782.00 |
| Jun 30, 2022 | -175,042.00 |
| Dec 31, 2019 | -1.40 Mn |
| Sep 30, 2016 | 6.30 Mn |
| Jun 30, 2016 | -6.26 Mn |
| Jun 30, 2014 | -140,945.00 |
| Mar 31, 2013 | -374,095.00 |
| Dec 31, 2012 | 120,588.00 |
| Sep 30, 2012 | 119,840.00 |
| Jun 30, 2012 | -319,564.00 |
| Mar 31, 2012 | 7,713.00 |
| Dec 31, 2011 | -62,923.00 |
| Sep 30, 2011 | 38,137.00 |
| Jun 30, 2011 | -18,866.00 |
| Mar 31, 2011 | -77,846.00 |